Bioptik Technology Incorporation

NT$20.80As of Sun 8 Nov 2026, 12:00 UTC
TPEx:4161Healthcare
Country Taiwan
PE (Fwd) •••
TSR 10Y CAGR (6.67%)
Div yield 3.36%
ROE 11.20%
Medical Devices
Beta (5Y) 0.28
PE TTM 11.30
TSR TTM (17.84%)
Mkt cap NT$1.244B
ROIC 6.31%
SE Grade™
Value
Quality
Moat
Consensus
Reference
NT$21
1.04%
(32.04%)
Hold 10|3|3|10|7
4Q25
1Q26
2Q26
3Q26
Earnings per shareNT$
0.29
0.31
0.33
0.32
8.23%
21.70%
16.80%
18.03%
RevenueNT$M
62.72
61.42
64.90
67.65
0.94%
(0.24%)
6.79%
6.46%
Peers (US$37.57M)
Cap (US$)
PE
40.82M
5.838x
36.43M
—
37.68M
0.928x
Capital
TTM
5Y
10Y
Leveragex
1.276
0.264
0.236
EBIT/Intx
1.916
2.162
1.830
Own earn%
(68.55)
120.74
121.06
Sh yield%
22.25
30.18
28.62
Owners
Insiders/Inst%
9.29
45.34
Short interest%
2.65
SBC / revenue%
1.57
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
9
Op margin range%
18–26
$1 testx
—
Incr. ROIC%
8